SRA International Wins $18M Contract to Support Vaccine Adverse Event Reporting System

Kamal Narang, SRA International Inc.

Kamal Narang, SRA International Inc.

SRA International Inc., a provider of IT solutions and professional services to government organizations, announced Nov. 17 the company has been awarded a contract to support the Vaccine Adverse Event Reporting System (VAERS) co-sponsored by the Centers for Disease Control and Prevention and the Food and Drug Administration.

“SRA is delighted to continue our partnership with the CDC and FDA on this important work,” SRA’s Health business VP Kamal Narang said. “We have supported this critical effort since 1999 and look forward to leveraging our in-depth public health knowledge and technical expertise to further enhance the vaccine adverse event reporting system and its operation, as well as aid the government in responding to the challenges created by newly licensed vaccines, evolving vaccination schedules and emergency immunization campaigns.”

The contract includes a base year, plus four option years, and is valued at $18 million if all options are exercised.

VAERS is a national vaccine safety program that collects reports from vaccine manufacturers, providers and recipients about possible side effects or adverse events that occur after the administration of vaccines licensed for use in the U.S.

The Fairfax, Va.-based SRA will support application development and maintenance, data processing/management, medical coding, clinical research, information technology and outreach to the public, vaccine manufacturers and immunization programs.

WashingtonExec last covered SRA with an interview on “Millennial Maverick” Brian Conn in October.

Comments are closed.

Subscribe to The DailyGet federal business news & insights delivered to your inbox.